Christopher J. Avery
Directeur des opérations chez MyWay Digital Health Ltd.
Profil
Christopher J.
Avery was the founder of Nipro Diagnostics (UK) Ltd.
which was founded in 2005, where he held the titles of Managing Director & Director until 2016.
Currently, he is the Chief Operating Officer at MyWay Digital Health Ltd.
since 2021.
In the past, he worked as MD-UK Region & Director-European Region at Trividia Health, Inc., Vice President-Global Business Operations at Nemaura Medical, Inc., Project Manager at Hypoguard Ltd., and Senior Vice President-Business Development at Dallas Burston Ethitronix Ltd.
Postes actifs de Christopher J. Avery
| Sociétés | Poste | Début |
|---|---|---|
MyWay Digital Health Ltd.
 MyWay Digital Health Ltd. Packaged SoftwareTechnology Services MyWay Digital Health Ltd. is a British company that focuses on digital health for patients and clinicians. The company is based in Dundee, UK. The company has a strong evidence base for their product, MyWay Diabetes, which is a diabetes self-management system with national deployment. The company is passionate about improving care for those living with diabetes and keeping the end users at the heart of their decision making. The company was founded in 2017 by Scott Cunningham and Debbie Wake, with Debbie Wake serving as the CEO since then. | Directeur des opérations | 01/12/2021 |
Anciens postes connus de Christopher J. Avery
| Sociétés | Poste | Fin |
|---|---|---|
Nipro Diagnostics (UK) Ltd.
 Nipro Diagnostics (UK) Ltd. Medical DistributorsDistribution Services Part of Sinocare, Inc., Nipro Diagnostics (UK) Ltd. is a British medical company that offers the 4sure portfolio for people with type 1 diabetes. The company is based in Southampton, UK. The portfolio provides everything needed for frequent testing, insulin dosing calculation, and ?-ketone testing, without compromising on ease of use. The company was founded by Christopher J. Avery. Nipro Diagnostics (UK was acquired by Trividia Health, Inc., part of Sinocare, Inc. from January 07, 2016 on May 10, 2005 for $1.80 million. | Fondateur | - |
| Dallas Burston Ethitronix Ltd. | Corporate Officer/Principal | - |
Trividia Health, Inc.
 Trividia Health, Inc. Medical SpecialtiesHealth Technology Trividia Health, Inc. develops, manufactures and markets diabetes monitoring and management products. It supplies blood glucose monitoring systems, cobranded under the TRUE name, to pharmacies, distributors and mail service providers. The company was founded by George H. Holley in 1985 and is headquartered in Fort Lauderdale, FL. | Corporate Officer/Principal | - |
| NEMAURA MEDICAL INC. | Corporate Officer/Principal | - |
| Hypoguard Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEMAURA MEDICAL INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Trividia Health, Inc.
Trividia Health, Inc. Medical SpecialtiesHealth Technology Trividia Health, Inc. develops, manufactures and markets diabetes monitoring and management products. It supplies blood glucose monitoring systems, cobranded under the TRUE name, to pharmacies, distributors and mail service providers. The company was founded by George H. Holley in 1985 and is headquartered in Fort Lauderdale, FL. | Health Technology |
| Hypoguard Ltd. | Health Technology |
Nipro Diagnostics (UK) Ltd.
Nipro Diagnostics (UK) Ltd. Medical DistributorsDistribution Services Part of Sinocare, Inc., Nipro Diagnostics (UK) Ltd. is a British medical company that offers the 4sure portfolio for people with type 1 diabetes. The company is based in Southampton, UK. The portfolio provides everything needed for frequent testing, insulin dosing calculation, and ?-ketone testing, without compromising on ease of use. The company was founded by Christopher J. Avery. Nipro Diagnostics (UK was acquired by Trividia Health, Inc., part of Sinocare, Inc. from January 07, 2016 on May 10, 2005 for $1.80 million. | Distribution Services |
| Dallas Burston Ethitronix Ltd. | |
MyWay Digital Health Ltd.
MyWay Digital Health Ltd. Packaged SoftwareTechnology Services MyWay Digital Health Ltd. is a British company that focuses on digital health for patients and clinicians. The company is based in Dundee, UK. The company has a strong evidence base for their product, MyWay Diabetes, which is a diabetes self-management system with national deployment. The company is passionate about improving care for those living with diabetes and keeping the end users at the heart of their decision making. The company was founded in 2017 by Scott Cunningham and Debbie Wake, with Debbie Wake serving as the CEO since then. | Technology Services |